Women’s health draws record $1.55bn in equity as capital spreads beyond the mega-rounds

Women’s health companies raised a record $1.55 billion in disclosed equity in 2025, up 41 per cent year on year, according to W Group’s first Global Women’s Health Investment Report, The Road to the Era of Scale.

The report tracks over 500 funding stories and 164 equity rounds across 15 categories and 30+ countries.

Eighty-five companies raised equity in 2025, the highest single-year count on record. But according to the report, the headline figure isn’t the most significant one.

The bigger shift is in where that capital went and how concentrated it was at the top compared to the year before.

The report also points to a brand new investment category that didn’t exist twelve months ago.

SheMed closed a $50 million Series A this year to build a women-specific GLP-1 and metabolic health platform, the first dedicated raise of its kind.

Alongside the momentum, the report identifies one structural risk that could determine whether 2025’s growth holds: a bottleneck at Series A that’s leaving a number of promising seed-stage companies stuck.

Molly Taylor, head of content at W Group, said: “2025 was the biggest year women’s health has ever had, and the most important finding isn’t the headline number.

“It’s that the money has stopped pooling at the top.

“Capital is reaching more companies, more categories and more countries than ever before. The Era of Scale is real. It’s just not finished, and the Series A gap is where it could stall.

“Closing that gap is the highest-leverage move this ecosystem can make in 2026.”

Read the full report: https://wplatform.co/forms/womens-health-equity-funding-trends-report-2026?utm_source=advocacy&utm_medium=ext_email&utm_campaign=2026-q3-health-report-femtech-world